Texas Medicaid Designates Pegfilgrastim-cbqv on the Preferred Drug List

March 15, 2021

For 2021, Texas Medicaid has designated pegfilgrastim-cbqv (Udenyca^®, Coherus Biosciences) the preferred pegfilgrastim on the Preferred Drug List (PDL). Udenyca^® coverage details are available here.

Please contact marketaccess@coherus.com for additional information.

Posted 3/15/2021

Upcoming Events

Oncology

ACCC 43rd National Oncology Conference

In Person Conference & ConventionOctober 21, 2026 at 8:00 AM MDT450 Summer St, Boston, MA 02210Omni Boston Hotel at the Seaport, Boston

Oncology

HSCO 2026 August Dinner Symposium

In Person Conference & ConventionAugust 12, 2026 at 5:30 PM HST6600 Kalanianaʻole Highway suite 110, Honolulu, HI 96825, USARoy's Restaurants – Hawaii Kai, Honolulu

Oncology

LOS 2026 Cancer Congress - National Oncology Updates

In Person Conference & ConventionAugust 14, 2026 at 11:00 AM CDT859 Convention Center Blvd, New Orleans, LA, USANew Orleans Marriott Warehouse Art District, New Orleans

Oncology

IOS Evansville Meeting

In Person Conference & ConventionAugust 18, 2026 at 5:30 PM CDT4011 Gateway Blvd, Newburgh, IN 47630, USADeaconess Gateway Hospital , Newburgh

Oncology

2026 Carolinas Cancer Conference

In Person Conference & ConventionAugust 22, 2026 at 7:00 AM EDT5757 Palm Blvd, Isle of Palms, SC, USAWild Dunes, Isle of Palms

Oncology

IOS 2026 Best of ASCO

In Person Conference & ConventionAugust 22, 2026 at 6:30 AM CDT300 East 9th Street, Coralville, IA, USAHyatt Regency Coralville Hotel & Conference Center, Coralville

Oncology

NMSCO 2026 Fall Conference

In Person Conference & ConventionSeptember 12, 2026 at 7:30 AM MDT2101 Louisiana Boulevard NE Albuquerque, NM, 87110Marriott Albuquerque, Albuquerque

Oncology

TxSCO 2026 Annual Conference

In Person Conference & ConventionSeptember 18, 2026 at 6:00 PM CDT501 Gaylord Trail, Grapevine, TX, USAGaylord Texan Resort & Convention Center, Grapevine

Trending Now on
ACCCBuzz Blog

Local Staff, Lasting Impact: A New Model for Rural Cancer Prevention

To better reach its patients living in rural communities throughout Georgia with targeted interventions, 2026 ACCC Innovator Award winner Winship Cancer Institute developed an Embedded Community Staff model, which leverages the experiential knowledge of local community members.

A Pharmacist-Led Strategy to Improve Care With Oncolytic Virus Treatments

2026 ACCC Innovator Award Winner UNC Lineberger Comprehensive Cancer Center noticed a common pain point among patients who received oncolytic virus treatment for advanced melanoma: time spent in appointments. To minimize the need for multiple lengthy appointments, the center developed a pharmacist-led strategy that utilized virtual visits and premixing doses prior to in-person visits.

Extending Patient-Centered Cancer Care to Transgender and Nonbinary Individuals

In a recent article from Oncology Issues, authors conducted a systematic literature review and found that two main drivers of care disparities exist for transgender and nonbinary individuals with cancer: rigid binary gender frameworks and gaps in mental health care.

Transforming Oncology Authorization Through Clinical and Revenue Cycle Collaboration

2026 ACCC Innovator Award Winner St. Luke's Cancer Institute noticed a significant administrative burden being placed on providers to review medical necessity validation for complex oncology therapies. To address the resulting rise in peer-to-peer requirements, delays in care, and pre-service denials, the team designed and implemented a new Clinical Documentation Integrity Registered Nurse role.

View All ACCCBuzz Blogs